
Addressing peptide therapeutics with a versatile pen platform
24/05/2023
Discussing the rising demand in peptide therapeutics and how Nemera’s PenVario pen injector platform, coupled with Nemera’s end-to-end service offering.
Continue Reading24/05/2023
Discussing the rising demand in peptide therapeutics and how Nemera’s PenVario pen injector platform, coupled with Nemera’s end-to-end service offering.
Continue Reading15/05/2023
Since its creation, Nemera has been resolutely focused on the wellbeing of patients, true to the motto, “We put patients first”, as well as the health and safety of its...
Continue Reading27/04/2023
Nemera presents its vision and solutions, including dry powder and soft mist devices, as alternatives to propellant gas emissions from pMDIs Léa Salfati and Gildas Huet at Nemera In 2022,...
Continue Reading27/04/2023
The overall Ear, Nose, and Throat (ENT) market was heavily impacted by Covid-19 pandemic due to masks-wearing, lockdown, and less social interactions, exposing people less to respiratory virus as well...
Continue Reading17/03/2023
The majority of eye drops today contain preservatives to maintain eye drop formulation’s sterility.
Continue Reading22/02/2023
The methods available to pharmaceutical companies and device suppliers to support the patient journey and experience are offering more possibilities than ever before.
Continue Reading